Global Sufentanil (API) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
LPI (LP Information)' newest research report, the “Sufentanil (API) Industry Forecast” looks at past sales and reviews total world Sufentanil (API) sales in 2022, providing a comprehensive analysis by region and market sector of projected Sufentanil (API) sales for 2023 through 2029. With Sufentanil (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sufentanil (API) industry.
This Insight Report provides a comprehensive analysis of the global Sufentanil (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sufentanil (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sufentanil (API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sufentanil (API) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sufentanil (API).
The global Sufentanil (API) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sufentanil (API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sufentanil (API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sufentanil (API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sufentanil (API) players cover Kern Pharma, Cambrex, Hameln Rds, Cristalia and Janssen Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sufentanil (API) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Sufentanil (API) market?
What factors are driving Sufentanil (API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sufentanil (API) market opportunities vary by end market size?
How does Sufentanil (API) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times as potent as its parent drug, fentanyl, and 500 times as potent as morphine.
LPI (LP Information)' newest research report, the “Sufentanil (API) Industry Forecast” looks at past sales and reviews total world Sufentanil (API) sales in 2022, providing a comprehensive analysis by region and market sector of projected Sufentanil (API) sales for 2023 through 2029. With Sufentanil (API) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sufentanil (API) industry.
This Insight Report provides a comprehensive analysis of the global Sufentanil (API) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sufentanil (API) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sufentanil (API) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sufentanil (API) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sufentanil (API).
The global Sufentanil (API) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sufentanil (API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sufentanil (API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sufentanil (API) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sufentanil (API) players cover Kern Pharma, Cambrex, Hameln Rds, Cristalia and Janssen Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Sufentanil (API) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Purity 98%
- Purity 99%
- Injection
- Capsule
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Kern Pharma
- Cambrex
- Hameln Rds
- Cristalia
- Janssen Pharmaceuticals
What is the 10-year outlook for the global Sufentanil (API) market?
What factors are driving Sufentanil (API) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sufentanil (API) market opportunities vary by end market size?
How does Sufentanil (API) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sufentanil (API) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sufentanil (API) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sufentanil (API) by Country/Region, 2018, 2022 & 2029
2.2 Sufentanil (API) Segment by Type
2.2.1 Purity 98%
2.2.2 Purity 99%
2.3 Sufentanil (API) Sales by Type
2.3.1 Global Sufentanil (API) Sales Market Share by Type (2018-2023)
2.3.2 Global Sufentanil (API) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sufentanil (API) Sale Price by Type (2018-2023)
2.4 Sufentanil (API) Segment by Application
2.4.1 Injection
2.4.2 Capsule
2.5 Sufentanil (API) Sales by Application
2.5.1 Global Sufentanil (API) Sale Market Share by Application (2018-2023)
2.5.2 Global Sufentanil (API) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sufentanil (API) Sale Price by Application (2018-2023)
3 GLOBAL SUFENTANIL (API) BY COMPANY
3.1 Global Sufentanil (API) Breakdown Data by Company
3.1.1 Global Sufentanil (API) Annual Sales by Company (2018-2023)
3.1.2 Global Sufentanil (API) Sales Market Share by Company (2018-2023)
3.2 Global Sufentanil (API) Annual Revenue by Company (2018-2023)
3.2.1 Global Sufentanil (API) Revenue by Company (2018-2023)
3.2.2 Global Sufentanil (API) Revenue Market Share by Company (2018-2023)
3.3 Global Sufentanil (API) Sale Price by Company
3.4 Key Manufacturers Sufentanil (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sufentanil (API) Product Location Distribution
3.4.2 Players Sufentanil (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SUFENTANIL (API) BY GEOGRAPHIC REGION
4.1 World Historic Sufentanil (API) Market Size by Geographic Region (2018-2023)
4.1.1 Global Sufentanil (API) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sufentanil (API) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sufentanil (API) Market Size by Country/Region (2018-2023)
4.2.1 Global Sufentanil (API) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sufentanil (API) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sufentanil (API) Sales Growth
4.4 APAC Sufentanil (API) Sales Growth
4.5 Europe Sufentanil (API) Sales Growth
4.6 Middle East & Africa Sufentanil (API) Sales Growth
5 AMERICAS
5.1 Americas Sufentanil (API) Sales by Country
5.1.1 Americas Sufentanil (API) Sales by Country (2018-2023)
5.1.2 Americas Sufentanil (API) Revenue by Country (2018-2023)
5.2 Americas Sufentanil (API) Sales by Type
5.3 Americas Sufentanil (API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sufentanil (API) Sales by Region
6.1.1 APAC Sufentanil (API) Sales by Region (2018-2023)
6.1.2 APAC Sufentanil (API) Revenue by Region (2018-2023)
6.2 APAC Sufentanil (API) Sales by Type
6.3 APAC Sufentanil (API) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sufentanil (API) by Country
7.1.1 Europe Sufentanil (API) Sales by Country (2018-2023)
7.1.2 Europe Sufentanil (API) Revenue by Country (2018-2023)
7.2 Europe Sufentanil (API) Sales by Type
7.3 Europe Sufentanil (API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sufentanil (API) by Country
8.1.1 Middle East & Africa Sufentanil (API) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sufentanil (API) Revenue by Country (2018-2023)
8.2 Middle East & Africa Sufentanil (API) Sales by Type
8.3 Middle East & Africa Sufentanil (API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sufentanil (API)
10.3 Manufacturing Process Analysis of Sufentanil (API)
10.4 Industry Chain Structure of Sufentanil (API)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sufentanil (API) Distributors
11.3 Sufentanil (API) Customer
12 WORLD FORECAST REVIEW FOR SUFENTANIL (API) BY GEOGRAPHIC REGION
12.1 Global Sufentanil (API) Market Size Forecast by Region
12.1.1 Global Sufentanil (API) Forecast by Region (2024-2029)
12.1.2 Global Sufentanil (API) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sufentanil (API) Forecast by Type
12.7 Global Sufentanil (API) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Kern Pharma
13.1.1 Kern Pharma Company Information
13.1.2 Kern Pharma Sufentanil (API) Product Portfolios and Specifications
13.1.3 Kern Pharma Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Kern Pharma Main Business Overview
13.1.5 Kern Pharma Latest Developments
13.2 Cambrex
13.2.1 Cambrex Company Information
13.2.2 Cambrex Sufentanil (API) Product Portfolios and Specifications
13.2.3 Cambrex Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cambrex Main Business Overview
13.2.5 Cambrex Latest Developments
13.3 Hameln Rds
13.3.1 Hameln Rds Company Information
13.3.2 Hameln Rds Sufentanil (API) Product Portfolios and Specifications
13.3.3 Hameln Rds Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hameln Rds Main Business Overview
13.3.5 Hameln Rds Latest Developments
13.4 Cristalia
13.4.1 Cristalia Company Information
13.4.2 Cristalia Sufentanil (API) Product Portfolios and Specifications
13.4.3 Cristalia Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cristalia Main Business Overview
13.4.5 Cristalia Latest Developments
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Information
13.5.2 Janssen Pharmaceuticals Sufentanil (API) Product Portfolios and Specifications
13.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Janssen Pharmaceuticals Main Business Overview
13.5.5 Janssen Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sufentanil (API) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sufentanil (API) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sufentanil (API) by Country/Region, 2018, 2022 & 2029
2.2 Sufentanil (API) Segment by Type
2.2.1 Purity 98%
2.2.2 Purity 99%
2.3 Sufentanil (API) Sales by Type
2.3.1 Global Sufentanil (API) Sales Market Share by Type (2018-2023)
2.3.2 Global Sufentanil (API) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sufentanil (API) Sale Price by Type (2018-2023)
2.4 Sufentanil (API) Segment by Application
2.4.1 Injection
2.4.2 Capsule
2.5 Sufentanil (API) Sales by Application
2.5.1 Global Sufentanil (API) Sale Market Share by Application (2018-2023)
2.5.2 Global Sufentanil (API) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sufentanil (API) Sale Price by Application (2018-2023)
3 GLOBAL SUFENTANIL (API) BY COMPANY
3.1 Global Sufentanil (API) Breakdown Data by Company
3.1.1 Global Sufentanil (API) Annual Sales by Company (2018-2023)
3.1.2 Global Sufentanil (API) Sales Market Share by Company (2018-2023)
3.2 Global Sufentanil (API) Annual Revenue by Company (2018-2023)
3.2.1 Global Sufentanil (API) Revenue by Company (2018-2023)
3.2.2 Global Sufentanil (API) Revenue Market Share by Company (2018-2023)
3.3 Global Sufentanil (API) Sale Price by Company
3.4 Key Manufacturers Sufentanil (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sufentanil (API) Product Location Distribution
3.4.2 Players Sufentanil (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SUFENTANIL (API) BY GEOGRAPHIC REGION
4.1 World Historic Sufentanil (API) Market Size by Geographic Region (2018-2023)
4.1.1 Global Sufentanil (API) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sufentanil (API) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sufentanil (API) Market Size by Country/Region (2018-2023)
4.2.1 Global Sufentanil (API) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sufentanil (API) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sufentanil (API) Sales Growth
4.4 APAC Sufentanil (API) Sales Growth
4.5 Europe Sufentanil (API) Sales Growth
4.6 Middle East & Africa Sufentanil (API) Sales Growth
5 AMERICAS
5.1 Americas Sufentanil (API) Sales by Country
5.1.1 Americas Sufentanil (API) Sales by Country (2018-2023)
5.1.2 Americas Sufentanil (API) Revenue by Country (2018-2023)
5.2 Americas Sufentanil (API) Sales by Type
5.3 Americas Sufentanil (API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sufentanil (API) Sales by Region
6.1.1 APAC Sufentanil (API) Sales by Region (2018-2023)
6.1.2 APAC Sufentanil (API) Revenue by Region (2018-2023)
6.2 APAC Sufentanil (API) Sales by Type
6.3 APAC Sufentanil (API) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Sufentanil (API) by Country
7.1.1 Europe Sufentanil (API) Sales by Country (2018-2023)
7.1.2 Europe Sufentanil (API) Revenue by Country (2018-2023)
7.2 Europe Sufentanil (API) Sales by Type
7.3 Europe Sufentanil (API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sufentanil (API) by Country
8.1.1 Middle East & Africa Sufentanil (API) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sufentanil (API) Revenue by Country (2018-2023)
8.2 Middle East & Africa Sufentanil (API) Sales by Type
8.3 Middle East & Africa Sufentanil (API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sufentanil (API)
10.3 Manufacturing Process Analysis of Sufentanil (API)
10.4 Industry Chain Structure of Sufentanil (API)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sufentanil (API) Distributors
11.3 Sufentanil (API) Customer
12 WORLD FORECAST REVIEW FOR SUFENTANIL (API) BY GEOGRAPHIC REGION
12.1 Global Sufentanil (API) Market Size Forecast by Region
12.1.1 Global Sufentanil (API) Forecast by Region (2024-2029)
12.1.2 Global Sufentanil (API) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sufentanil (API) Forecast by Type
12.7 Global Sufentanil (API) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Kern Pharma
13.1.1 Kern Pharma Company Information
13.1.2 Kern Pharma Sufentanil (API) Product Portfolios and Specifications
13.1.3 Kern Pharma Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Kern Pharma Main Business Overview
13.1.5 Kern Pharma Latest Developments
13.2 Cambrex
13.2.1 Cambrex Company Information
13.2.2 Cambrex Sufentanil (API) Product Portfolios and Specifications
13.2.3 Cambrex Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cambrex Main Business Overview
13.2.5 Cambrex Latest Developments
13.3 Hameln Rds
13.3.1 Hameln Rds Company Information
13.3.2 Hameln Rds Sufentanil (API) Product Portfolios and Specifications
13.3.3 Hameln Rds Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hameln Rds Main Business Overview
13.3.5 Hameln Rds Latest Developments
13.4 Cristalia
13.4.1 Cristalia Company Information
13.4.2 Cristalia Sufentanil (API) Product Portfolios and Specifications
13.4.3 Cristalia Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cristalia Main Business Overview
13.4.5 Cristalia Latest Developments
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Information
13.5.2 Janssen Pharmaceuticals Sufentanil (API) Product Portfolios and Specifications
13.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Janssen Pharmaceuticals Main Business Overview
13.5.5 Janssen Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sufentanil (API) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sufentanil (API) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity 98%
Table 4. Major Players of Purity 99%
Table 5. Global Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 6. Global Sufentanil (API) Sales Market Share by Type (2018-2023)
Table 7. Global Sufentanil (API) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sufentanil (API) Revenue Market Share by Type (2018-2023)
Table 9. Global Sufentanil (API) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 11. Global Sufentanil (API) Sales Market Share by Application (2018-2023)
Table 12. Global Sufentanil (API) Revenue by Application (2018-2023)
Table 13. Global Sufentanil (API) Revenue Market Share by Application (2018-2023)
Table 14. Global Sufentanil (API) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Sufentanil (API) Sales by Company (2018-2023) & (K Units)
Table 16. Global Sufentanil (API) Sales Market Share by Company (2018-2023)
Table 17. Global Sufentanil (API) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sufentanil (API) Revenue Market Share by Company (2018-2023)
Table 19. Global Sufentanil (API) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Sufentanil (API) Producing Area Distribution and Sales Area
Table 21. Players Sufentanil (API) Products Offered
Table 22. Sufentanil (API) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sufentanil (API) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Sufentanil (API) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sufentanil (API) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sufentanil (API) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sufentanil (API) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Sufentanil (API) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sufentanil (API) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sufentanil (API) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sufentanil (API) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Sufentanil (API) Sales Market Share by Country (2018-2023)
Table 35. Americas Sufentanil (API) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sufentanil (API) Revenue Market Share by Country (2018-2023)
Table 37. Americas Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Sufentanil (API) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Sufentanil (API) Sales Market Share by Region (2018-2023)
Table 41. APAC Sufentanil (API) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sufentanil (API) Revenue Market Share by Region (2018-2023)
Table 43. APAC Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Sufentanil (API) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Sufentanil (API) Sales Market Share by Country (2018-2023)
Table 47. Europe Sufentanil (API) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sufentanil (API) Revenue Market Share by Country (2018-2023)
Table 49. Europe Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Sufentanil (API) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Sufentanil (API) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sufentanil (API) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sufentanil (API) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Sufentanil (API)
Table 58. Key Market Challenges & Risks of Sufentanil (API)
Table 59. Key Industry Trends of Sufentanil (API)
Table 60. Sufentanil (API) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sufentanil (API) Distributors List
Table 63. Sufentanil (API) Customer List
Table 64. Global Sufentanil (API) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Sufentanil (API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sufentanil (API) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Sufentanil (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sufentanil (API) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Sufentanil (API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sufentanil (API) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Sufentanil (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sufentanil (API) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Sufentanil (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sufentanil (API) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Sufentanil (API) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sufentanil (API) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Sufentanil (API) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Kern Pharma Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 79. Kern Pharma Sufentanil (API) Product Portfolios and Specifications
Table 80. Kern Pharma Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Kern Pharma Main Business
Table 82. Kern Pharma Latest Developments
Table 83. Cambrex Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Sufentanil (API) Product Portfolios and Specifications
Table 85. Cambrex Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Cambrex Main Business
Table 87. Cambrex Latest Developments
Table 88. Hameln Rds Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 89. Hameln Rds Sufentanil (API) Product Portfolios and Specifications
Table 90. Hameln Rds Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Hameln Rds Main Business
Table 92. Hameln Rds Latest Developments
Table 93. Cristalia Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 94. Cristalia Sufentanil (API) Product Portfolios and Specifications
Table 95. Cristalia Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Cristalia Main Business
Table 97. Cristalia Latest Developments
Table 98. Janssen Pharmaceuticals Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 99. Janssen Pharmaceuticals Sufentanil (API) Product Portfolios and Specifications
Table 100. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Janssen Pharmaceuticals Main Business
Table 102. Janssen Pharmaceuticals Latest Developments
Table 1. Sufentanil (API) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sufentanil (API) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity 98%
Table 4. Major Players of Purity 99%
Table 5. Global Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 6. Global Sufentanil (API) Sales Market Share by Type (2018-2023)
Table 7. Global Sufentanil (API) Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sufentanil (API) Revenue Market Share by Type (2018-2023)
Table 9. Global Sufentanil (API) Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 11. Global Sufentanil (API) Sales Market Share by Application (2018-2023)
Table 12. Global Sufentanil (API) Revenue by Application (2018-2023)
Table 13. Global Sufentanil (API) Revenue Market Share by Application (2018-2023)
Table 14. Global Sufentanil (API) Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Sufentanil (API) Sales by Company (2018-2023) & (K Units)
Table 16. Global Sufentanil (API) Sales Market Share by Company (2018-2023)
Table 17. Global Sufentanil (API) Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sufentanil (API) Revenue Market Share by Company (2018-2023)
Table 19. Global Sufentanil (API) Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Sufentanil (API) Producing Area Distribution and Sales Area
Table 21. Players Sufentanil (API) Products Offered
Table 22. Sufentanil (API) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sufentanil (API) Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Sufentanil (API) Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sufentanil (API) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sufentanil (API) Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sufentanil (API) Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Sufentanil (API) Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sufentanil (API) Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sufentanil (API) Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sufentanil (API) Sales by Country (2018-2023) & (K Units)
Table 34. Americas Sufentanil (API) Sales Market Share by Country (2018-2023)
Table 35. Americas Sufentanil (API) Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sufentanil (API) Revenue Market Share by Country (2018-2023)
Table 37. Americas Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 38. Americas Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 39. APAC Sufentanil (API) Sales by Region (2018-2023) & (K Units)
Table 40. APAC Sufentanil (API) Sales Market Share by Region (2018-2023)
Table 41. APAC Sufentanil (API) Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sufentanil (API) Revenue Market Share by Region (2018-2023)
Table 43. APAC Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 44. APAC Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 45. Europe Sufentanil (API) Sales by Country (2018-2023) & (K Units)
Table 46. Europe Sufentanil (API) Sales Market Share by Country (2018-2023)
Table 47. Europe Sufentanil (API) Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sufentanil (API) Revenue Market Share by Country (2018-2023)
Table 49. Europe Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 50. Europe Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Sufentanil (API) Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Sufentanil (API) Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sufentanil (API) Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sufentanil (API) Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sufentanil (API) Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Sufentanil (API) Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Sufentanil (API)
Table 58. Key Market Challenges & Risks of Sufentanil (API)
Table 59. Key Industry Trends of Sufentanil (API)
Table 60. Sufentanil (API) Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sufentanil (API) Distributors List
Table 63. Sufentanil (API) Customer List
Table 64. Global Sufentanil (API) Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Sufentanil (API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sufentanil (API) Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Sufentanil (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sufentanil (API) Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Sufentanil (API) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sufentanil (API) Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Sufentanil (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sufentanil (API) Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Sufentanil (API) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sufentanil (API) Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Sufentanil (API) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sufentanil (API) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Sufentanil (API) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Kern Pharma Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 79. Kern Pharma Sufentanil (API) Product Portfolios and Specifications
Table 80. Kern Pharma Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Kern Pharma Main Business
Table 82. Kern Pharma Latest Developments
Table 83. Cambrex Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 84. Cambrex Sufentanil (API) Product Portfolios and Specifications
Table 85. Cambrex Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Cambrex Main Business
Table 87. Cambrex Latest Developments
Table 88. Hameln Rds Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 89. Hameln Rds Sufentanil (API) Product Portfolios and Specifications
Table 90. Hameln Rds Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Hameln Rds Main Business
Table 92. Hameln Rds Latest Developments
Table 93. Cristalia Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 94. Cristalia Sufentanil (API) Product Portfolios and Specifications
Table 95. Cristalia Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Cristalia Main Business
Table 97. Cristalia Latest Developments
Table 98. Janssen Pharmaceuticals Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 99. Janssen Pharmaceuticals Sufentanil (API) Product Portfolios and Specifications
Table 100. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Janssen Pharmaceuticals Main Business
Table 102. Janssen Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Sufentanil (API)
Figure 2. Sufentanil (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sufentanil (API) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Sufentanil (API) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sufentanil (API) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity 98%
Figure 10. Product Picture of Purity 99%
Figure 11. Global Sufentanil (API) Sales Market Share by Type in 2022
Figure 12. Global Sufentanil (API) Revenue Market Share by Type (2018-2023)
Figure 13. Sufentanil (API) Consumed in Injection
Figure 14. Global Sufentanil (API) Market: Injection (2018-2023) & (K Units)
Figure 15. Sufentanil (API) Consumed in Capsule
Figure 16. Global Sufentanil (API) Market: Capsule (2018-2023) & (K Units)
Figure 17. Global Sufentanil (API) Sales Market Share by Application (2022)
Figure 18. Global Sufentanil (API) Revenue Market Share by Application in 2022
Figure 19. Sufentanil (API) Sales Market by Company in 2022 (K Units)
Figure 20. Global Sufentanil (API) Sales Market Share by Company in 2022
Figure 21. Sufentanil (API) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Sufentanil (API) Revenue Market Share by Company in 2022
Figure 23. Global Sufentanil (API) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Sufentanil (API) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Sufentanil (API) Sales 2018-2023 (K Units)
Figure 26. Americas Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Sufentanil (API) Sales 2018-2023 (K Units)
Figure 28. APAC Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Sufentanil (API) Sales 2018-2023 (K Units)
Figure 30. Europe Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Sufentanil (API) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Sufentanil (API) Sales Market Share by Country in 2022
Figure 34. Americas Sufentanil (API) Revenue Market Share by Country in 2022
Figure 35. Americas Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 36. Americas Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 37. United States Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Sufentanil (API) Sales Market Share by Region in 2022
Figure 42. APAC Sufentanil (API) Revenue Market Share by Regions in 2022
Figure 43. APAC Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 44. APAC Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 45. China Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Sufentanil (API) Sales Market Share by Country in 2022
Figure 53. Europe Sufentanil (API) Revenue Market Share by Country in 2022
Figure 54. Europe Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 55. Europe Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 56. Germany Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Sufentanil (API) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Sufentanil (API) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Sufentanil (API) in 2022
Figure 71. Manufacturing Process Analysis of Sufentanil (API)
Figure 72. Industry Chain Structure of Sufentanil (API)
Figure 73. Channels of Distribution
Figure 74. Global Sufentanil (API) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Sufentanil (API) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Sufentanil (API) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Sufentanil (API) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Sufentanil (API) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Sufentanil (API) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Sufentanil (API)
Figure 2. Sufentanil (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sufentanil (API) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Sufentanil (API) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sufentanil (API) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity 98%
Figure 10. Product Picture of Purity 99%
Figure 11. Global Sufentanil (API) Sales Market Share by Type in 2022
Figure 12. Global Sufentanil (API) Revenue Market Share by Type (2018-2023)
Figure 13. Sufentanil (API) Consumed in Injection
Figure 14. Global Sufentanil (API) Market: Injection (2018-2023) & (K Units)
Figure 15. Sufentanil (API) Consumed in Capsule
Figure 16. Global Sufentanil (API) Market: Capsule (2018-2023) & (K Units)
Figure 17. Global Sufentanil (API) Sales Market Share by Application (2022)
Figure 18. Global Sufentanil (API) Revenue Market Share by Application in 2022
Figure 19. Sufentanil (API) Sales Market by Company in 2022 (K Units)
Figure 20. Global Sufentanil (API) Sales Market Share by Company in 2022
Figure 21. Sufentanil (API) Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Sufentanil (API) Revenue Market Share by Company in 2022
Figure 23. Global Sufentanil (API) Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Sufentanil (API) Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Sufentanil (API) Sales 2018-2023 (K Units)
Figure 26. Americas Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 27. APAC Sufentanil (API) Sales 2018-2023 (K Units)
Figure 28. APAC Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 29. Europe Sufentanil (API) Sales 2018-2023 (K Units)
Figure 30. Europe Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Sufentanil (API) Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Sufentanil (API) Revenue 2018-2023 ($ Millions)
Figure 33. Americas Sufentanil (API) Sales Market Share by Country in 2022
Figure 34. Americas Sufentanil (API) Revenue Market Share by Country in 2022
Figure 35. Americas Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 36. Americas Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 37. United States Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Sufentanil (API) Sales Market Share by Region in 2022
Figure 42. APAC Sufentanil (API) Revenue Market Share by Regions in 2022
Figure 43. APAC Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 44. APAC Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 45. China Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Sufentanil (API) Sales Market Share by Country in 2022
Figure 53. Europe Sufentanil (API) Revenue Market Share by Country in 2022
Figure 54. Europe Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 55. Europe Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 56. Germany Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Sufentanil (API) Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Sufentanil (API) Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Sufentanil (API) Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Sufentanil (API) Sales Market Share by Application (2018-2023)
Figure 65. Egypt Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Sufentanil (API) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Sufentanil (API) in 2022
Figure 71. Manufacturing Process Analysis of Sufentanil (API)
Figure 72. Industry Chain Structure of Sufentanil (API)
Figure 73. Channels of Distribution
Figure 74. Global Sufentanil (API) Sales Market Forecast by Region (2024-2029)
Figure 75. Global Sufentanil (API) Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Sufentanil (API) Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Sufentanil (API) Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Sufentanil (API) Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Sufentanil (API) Revenue Market Share Forecast by Application (2024-2029)
